These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30309498)

  • 21. Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors.
    Im KS; Kim IH; Kim NH; Lim HY; Kim JH; Sur JH
    Vet J; 2013 Mar; 195(3):366-72. PubMed ID: 22901454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366.
    Caceres S; Peña L; de Andres PJ; Illera MJ; Lopez MS; Woodward WA; Reuben JM; Illera JC
    PLoS One; 2015; 10(3):e0122277. PubMed ID: 25807360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature.
    Ferletta M; Grawé J; Hellmén E
    Int J Dev Biol; 2011; 55(7-9):791-9. PubMed ID: 22161835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of a canine xenograft model of inflammatory mammary carcinoma.
    Camacho L; Peña L; González Gil A; Cáceres S; Díez L; Illera JC
    Res Vet Sci; 2013 Dec; 95(3):1068-75. PubMed ID: 23972378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.
    Schlienger S; Campbell S; Pasquin S; Gaboury L; Claing A
    Oncotarget; 2016 Mar; 7(13):15811-27. PubMed ID: 26908458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AGR2-mediated unconventional secretion of 14-3-3ε and α-actinin-4, responsive to ER stress and autophagy, drives chemotaxis in canine mammary tumor cells.
    Yuan SH; Wu CC; Wang YC; Chan XY; Chu HW; Yang Y; Liu HP
    Cell Mol Biol Lett; 2024 May; 29(1):84. PubMed ID: 38822246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit tumor growth of human triple negative breast cancer.
    Zhu Z; Wang S; Zhu J; Yang Q; Dong H; Huang J
    Biol Chem; 2016 Oct; 397(10):1087-95. PubMed ID: 27186677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors.
    Sammarco A; Gomiero C; Beffagna G; Cavicchioli L; Ferro S; Michieletto S; Orvieto E; Patruno M; Zappulli V
    Animals (Basel); 2023 Feb; 13(5):. PubMed ID: 36899736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematogenic Dissemination of Triple-negative Versus Hormonal Receptor-positive Breast Cancer Cells.
    Carvalho MJ; Abrantes AM; Laranjo M; Paiva B; Torgal I; Cabrita AS; Botelho F; DE Oliveira CF
    In Vivo; 2015; 29(4):435-44. PubMed ID: 26130788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.
    Kim NH; Lim HY; Im KS; Kim JH; Sur JH
    J Comp Pathol; 2013 May; 148(4):298-306. PubMed ID: 23079102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.
    Chang CY; Chiou PP; Chen WJ; Li YH; Yiu JC; Cheng YH; Chen SD; Lin CT; Lai YS
    Res Vet Sci; 2010 Apr; 88(2):285-93. PubMed ID: 19748110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressiveness.
    de Oliveira JT; Santos AL; Gomes C; Barros R; Ribeiro C; Mendes N; de Matos AJ; Vasconcelos MH; Oliveira MJ; Reis CA; Gärtner F
    PLoS One; 2015; 10(4):e0121590. PubMed ID: 25850034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
    Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
    BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breed- and age-related differences in canine mammary tumors.
    Kim HW; Lim HY; Shin JI; Seung BJ; Ju JH; Sur JH
    Can J Vet Res; 2016 Apr; 80(2):146-55. PubMed ID: 27127342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
    Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
    Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44+/CD24- Cancer Stem Cells Are Associated With Higher Grade of Canine Mammary Carcinomas.
    Im KS; Jang YG; Shin JI; Kim NH; Lim HY; Lee SM; Kim JH; Sur JH
    Vet Pathol; 2015 Nov; 52(6):1041-4. PubMed ID: 26173453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine.
    Bird RC; Deinnocentes P; Church Bird AE; van Ginkel FW; Lindquist J; Smith BF
    Cancer Immunol Immunother; 2011 Jan; 60(1):87-97. PubMed ID: 21069323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs.
    Król M; Polańska J; Pawłowski KM; Turowski P; Skierski J; Majewska A; Ugorski M; Morty RE; Motyl T
    J Appl Genet; 2010; 51(1):37-50. PubMed ID: 20145299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
    Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
    Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.
    Abadie J; Nguyen F; Loussouarn D; Peña L; Gama A; Rieder N; Belousov A; Bemelmans I; Jaillardon L; Ibisch C; Campone M
    Breast Cancer Res Treat; 2018 Jan; 167(2):459-468. PubMed ID: 29063312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.